BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hałasa M, Łuszczki JJ, Dmoszyńska-Graniczka M, Baran M, Okoń E, Stepulak A, Wawruszak A. Antagonistic Interaction between Histone Deacetylase Inhibitor: Cambinol and Cisplatin-An Isobolographic Analysis in Breast Cancer In Vitro Models. Int J Mol Sci 2021;22:8573. [PMID: 34445277 DOI: 10.3390/ijms22168573] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Fan M, Hu J, Sha J, Zhang H, Wang Z, Zhang J, Wang S, Zheng S, Li W. Maltol, a naturally occurring flavor enhancer, ameliorates cisplatin-induced apoptosis by inhibiting NLRP3 inflammasome activation by modulating ROS-mediated oxidative stress. Journal of Functional Foods 2022;94:105127. [DOI: 10.1016/j.jff.2022.105127] [Reference Citation Analysis]
2 Wawruszak A, Luszczki J, Okon E, Czerwonka A, Stepulak A. Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis. Int J Mol Sci 2022;23:6458. [PMID: 35742901 DOI: 10.3390/ijms23126458] [Reference Citation Analysis]
3 Wawruszak A, Okon E, Telejko I, Czerwonka A, Luszczki J. Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells. Pharmacol Rep 2022. [PMID: 35900723 DOI: 10.1007/s43440-022-00393-w] [Reference Citation Analysis]
4 Wawruszak A, Borkiewicz L, Okon E, Kukula-Koch W, Afshan S, Halasa M. Vorinostat (SAHA) and Breast Cancer: An Overview. Cancers (Basel) 2021;13:4700. [PMID: 34572928 DOI: 10.3390/cancers13184700] [Reference Citation Analysis]